Peripheral Assent

in The Cuban Cure

Published by University of Chicago Press

Published in print December 2010 | ISBN: 9780226709178
Published online March 2013 | e-ISBN: 9780226709192 | DOI:
Peripheral Assent

More Like This

Show all results sharing this subject:

  • History of Science and Technology


Show Summary Details


This chapter examines the growth of the biotechnology sector in Cuba. It explores Cuba's various attempts to define its biotechnology and its efforts to maintain a space for that science amid a rather differently couched global pharmaceutical norm. It mentions that the Center for Molecular Immunology's (CIM) TheraCIM drug was granted a U.S. patent in 1999 and an in-depth article on the CIM–York Medical partnership was featured in the July 2000 issue of Journal of the National Cancer Institute.

Keywords: biotechnology; Cuba; global pharmaceutical norm; CIM; TheraCIM; drug patent; York Medical; Jounral of the National Cancer Institute

Chapter.  9084 words. 

Subjects: History of Science and Technology

Full text: subscription required

How to subscribe Recommend to my Librarian

Users without a subscription are not able to see the full content. Please, subscribe or login to access all content.